Regeneron Pharmaceuticals, Inc.

(NASDAQ Global Select)
Somewhat Bearish -40

Stocks making the biggest moves midday: Regeneron, Dominion, Mobileye, Viking and more

πŸ“ˆ Dominion Energy shares jumped over 9% after NextEra Energy agreed to acquire the company in an all-stock deal.

⚑ The merger would combine the two firms into the world's largest regulated electric utility business.

πŸ“‰ NextEra Energy shares fell about 5% following the announcement of the acquisition.

πŸ›³οΈ Viking Holdings stock rose nearly 2% after Wells Fargo upgraded its rating to overweight.

✈️ Analysts cited stronger-than-expected bookings and resilient demand for Viking despite fears related to the Iran war.

πŸ€– Mobileye shares dropped almost 8% after Jefferies initiated coverage with an underperform rating.

⚠️ The analyst warned that Mobileye faces heightened competitive pressure and has priced in upside from autonomy improvements.

πŸ’° Cognizant Technology Solutions shares rose nearly 7% after doubling its share repurchase target to $2 billion for 2026.

❀️ Boston Scientific shares gained over 3% on plans for a $2 billion accelerated stock buyback program.

πŸ”¬ Boston Scientific also announced a $1.5 billion investment in MiRus to reenter the transcatheter aortic valve replacement market.

🧬 Regeneron Pharmaceuticals shares fell more than 10% after its skin cancer treatment missed late-stage trial goals.

πŸ‘— Macy's stock rose about 1% after reports revealed Berkshire Hathaway initiated a small $55 million position in the company.

✈️ Delta Air Lines shares were up over 1% after filings showed Berkshire Hathaway took a $2.6 billion stake in the airline.

πŸ€– ServiceNow shares jumped 6% following Bank of America reinitiating coverage with a buy rating citing AI benefits.

πŸ”‹ Ford Motor stock spiked after announcing a five-year agreement to produce up to 4 gigawatt hours of battery energy storage annually.

Bullish Signals
  • Dominion Energy shares popped more than 9% after NextEra Energy announced a deal to acquire the company in an all-stock transaction.
  • Viking Holdings stock rose nearly 2% after an upgrade from Wells Fargo to overweight, citing stronger-than-expected bookings and resilient demand despite fears associated with the ongoing Iran war.
  • Advanced bookings for Viking for 2027 already have risen 31% from the prior year according to Wells Fargo.
  • Cognizant Technology Solutions shares rose nearly 7% after the company doubled its share repurchase target for this year to about $2 billion in 2026.
  • Boston Scientific shares rose more than 3% on plans for a $2 billion accelerated stock repurchase plan.
  • Boston Scientific also made a $1.5 billion investment in a privately held heart valve business, MiRus, enabling reentry into the transcatheter aortic value replacement market.
  • Macy's shares rose about 1% after a regulatory filing revealed Berkshire Hathaway initiated a small position valued at roughly $55 million.
  • Bio Rad Laboratories stock jumped 11% following a Wall Street Journal report that activist Elliott Investment Management has built a sizable stake in the company.
  • Delta Air Lines shares were up more than 1% after a regulatory filing showed Berkshire Hathaway took a sizable stake totaling $2.6 billion in the airline.
  • ServiceNow shares jumped 6% following Bank of America reinitiating coverage with a buy rating, noting the company will likely benefit from AI rather than be replaced by it.
  • Ford Motor stock spiked after Ford Energy and EDF power solutions North America announced a five-year agreement to produce up to 4 gigawatt hours of direct current Block Battery energy storage systems annually, with deliveries expected to begin in 2028.
Risk Factors
  • Regeneron Pharmaceuticals shares fell more than 10% after its treatment for a skin cancer missed goals in a late-stage trial.
  • Mobileye shares dropped almost 8% following an initiation of an underperform rating at Jefferies, which warned the company faces heightened competitive pressure and has already priced in upside from improved autonomy systems.
Full Analysis
Regeneron Pharmaceuticals shares fell more than 10% in midday trading after the company's late-stage trial for a skin cancer treatment missed its primary goals. This specific news caused the significant market movement, distinguishing it from other tickers like Dominion Energy, Mobileye, and Viking Holdings mentioned in the list. The article notes that Regeneron is not the only company with major moves; Dominion Energy jumped over 9% following an acquisition announcement by NextEra Energy, while Mobileye dropped 8% after an underperform rating from Jefferies citing competitive pressure. Additionally, Viking Holdings rose nearly 2% on a Wells Fargo upgrade based on strong booking figures for 2027, and Boston Scientific increased more than 3% after announcing a $2 billion accelerated stock repurchase plan and investing in a heart valve business. The piece also details other market movers including Cognizant Technology Solutions doubling its buyback target, Macy's rising slightly due to a Berkshire Hathaway stake, and Delta Air Lines seeing gains from another significant Berkshire investment. While the text includes generic boilerplate about newsletter signups and data disclaimers, the substantive reporting on Regeneron's failed trial and its impact on stock price is clear and specific.